Amicus Therapeutics: Fourth Quarter Financial Results Overview

Amicus Therapeutics Announces Fourth-Quarter Financial Results

Amicus Therapeutics Inc., headquartered in Princeton, New Jersey, reported a net profit of $1.7 million for the fourth quarter.

The company achieved earnings of $0.01 per share. After adjusting for expenses related to stock options and amortization, adjusted earnings stood at $0.10 per share.

These earnings were below what analysts had anticipated. According to a survey conducted by Zacks Investment Research among three analysts, the consensus estimate was $0.13 per share.

Amicus Therapeutics generated $185.2 million in revenue during the quarter, surpassing analyst expectations, which averaged $179.9 million according to Zacks.

Looking at the full year, the company reported a net loss of $27.1 million, or $0.09 per share, with total revenue reaching $634.2 million.